Healthy Volunteer COVID-19 Antibody Testing Study
NCT04529460 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2021-10-14
Summary
The need for large-scale testing for COVID-19 has been highlighted by both the World Health Organization (WHO) and the UK government.
Immunity to coronavirus 2019 (COVID-19) infection can be determined by detecting the presence of antibodies to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Immunoglobulins (Ig) to the SARS-CoV-2 develop during the second and third week of COVID-19 disease and can be detected by analyses conducted using laboratory tests. Accurate and scalable point-of-care testing (POCT) for the diagnosis of COVID-19 immunity would allow community diagnostic to be upscaled enormously. POCT for COVID-19 antibodies is possible using small disposable kits. POCT immunity testing using disposable kits will be imperative for effective surveillance and vaccinations programmes.
The study aims to test a novel, rapid antibody testing kit (IgG and IgM) in order to confirm its accuracy in a healthy volunteer population. The antibody testing kit intended for use in the study has already been CE marked for this purpose.
Conditions
- Covid19
Interventions
- DIAGNOSTIC_TEST
-
COVID-19 antibody point of care test kit
A disponible point of care test that identifies the presence of antibodies to COVID-19
Sponsors & Collaborators
-
Royal Free Hospital NHS Foundation Trust
lead OTHER
Principal Investigators
-
Daniel Martin, MB ChB · Royal Free Hospital NHS Foundation Trust
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-09-01
- Primary Completion
- 2021-01-29
- Completion
- 2021-04-30
More Related Trials
-
BinaxNow COVID-19 IgG Rapid Test Device and Antibody Self Test
NCT04959760 ·Status: COMPLETED ·Phase: NA
-
ANTIBODY BASED TESTS FOR SARSCoV-2 COVID-19) - Evaluation of Patients and Healthcare Providers in the Confines of Healthcare Settings
NCT04352764 ·Status: UNKNOWN
-
COVID Card Pilot Study to Detect Antibodies to SARS-CoV-2
NCT05196932 ·Status: COMPLETED
-
SARS-CoV-2 Nucleic Acid Detection Kit Clinical Performance Study
NCT05492227 ·Status: COMPLETED
-
At-Home COVID-19 Antibody Test Usability Assessment & Behavior Change Study
NCT04393961 ·Status: UNKNOWN ·Phase: NA
-
Convalescent Plasma Donor Vaccine Study An Observational Antibody Level Study.
NCT04954937 ·Status: UNKNOWN
-
300 Antibody Diagnostic Test Kit
NCT01646411 ·Status: UNKNOWN
-
NOWDx Test for the Detection of Antibodies to COVID-19
NCT04690413 ·Status: COMPLETED ·Phase: NA
-
COVID-19 Immunity Assessment
NCT05080231 ·Status: COMPLETED
-
COVID-19: A POC Test Under Research & Evaluation
NCT04408066 ·Status: SUSPENDED ·Phase: NA
-
Diagnostics of COVID-19/DARTS (Development and Assessment of Rapid Testing for SARS-CoV-2 Outbreak)
NCT04351646 ·Status: UNKNOWN
-
COVID-19 Diagnostic Self-testing Using Virtual Point-of-care
NCT04348864 ·Status: UNKNOWN ·Phase: NA
-
Clinical Evaluation of a COVID-19 Antigen Self-Test (CoviDx™)
NCT05403346 ·Status: TERMINATED
-
TekiTrust Tests to Determine the Level of SARS-COV-2/COVID-19 Neutralizing Antibodies in the Blood
NCT05338762 ·Status: COMPLETED
-
COVID-19 MP Biomedicals Rapid SARS-CoV-2 Antigen Test Usability
NCT05584189 ·Status: COMPLETED ·Phase: NA
-
EuGeni Rapid Antigen Test for the Qualitative Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Causing COVID19 Disease in Compliance With the World Health Organization (WHO)
NCT05618561 ·Status: TERMINATED
-
Clinical Performance Evaluation of the CareSuperb™ COVID-19 Antigen Home Test
NCT05771714 ·Status: TERMINATED ·Phase: NA
-
Research & Evaluation of LumiraDx SARS-CoV-2 (COVID-19) Point of Care Ab Test
NCT04597047 ·Status: UNKNOWN ·Phase: NA
-
Convalescent Plasma as Treatment for Subjects With Early COVID-19 Infection
NCT04456413 ·Status: TERMINATED ·Phase: PHASE2
-
In-vitro Diagnostic Test to Predict COVID-19 Mortality and Disease Severity
NCT04368897 ·Status: WITHDRAWN
-
Donated Antibodies Working Against nCoV
NCT04429854 ·Status: COMPLETED ·Phase: PHASE2
-
Convalescent Plasma for the Treatment of Patients With COVID-19
NCT04372368 ·Status: NO_LONGER_AVAILABLE
-
Comparison of the ID NOW and Accula Point-of-Care Assays for Detection of COVID-19
NCT04403035 ·Status: WITHDRAWN
-
Acquiring Convalescent Specimens for COVID-19 Antibodies
NCT04342195 ·Status: COMPLETED
-
Utilizing Novel Blood RNA Biomarkers as a Diagnostic Tool in the Identification of Long COVID-19
NCT06311435 ·Status: RECRUITING ·Phase: NA